TGFB1 and breast carcinoma: Together, these data further support the value of Tgfbr2MyeKO mice as a relevant in vivo model of tumor dormancy using multiple mouse breast cancer cell lines and reveal that while suppressing gross tumor outgrowth, the loss of TGFb signaling in myeloid cells promotes survival of metastatic tumor cells in a dormant state.